Followers
0
Following
0
Blog Posts
0
Threads
1,139
Blogs
Threads
Portfolio
Follower
Following
2020-11-13 11:34 | Report Abuse
DJ -400++, S&P -90++
Clearly the US market already knows that Pfizers Vaccine will not be a practical solution. The vaccines will be useless once exposed to room temp. Even if SATs say they the ultra freezing equipment, what about the trucks from manufacture to the aircraft, the aircraft cargo, ground transporters, hospitals in major cities, etc, etc.
2020-11-13 11:32 | Report Abuse
DJ -400++, S&P -90++
Clearly the US market already knows that Pfizers Vaccine will not be a practical solution. The vaccines will be useless once exposed to room temp. Even if SATs say they the ultra freezing equipment, what about the trucks from manufacture to the aircraft, the aircraft cargo, ground transporters, hospitals in major cities, etc, etc.
2020-11-13 11:31 | Report Abuse
DJ -400++, S&P -90++
Clearly the US market already knows that Pfizers Vaccine will not be a practical solution. The vaccines will be useless once exposed to room temp. Even if SATs say they the ultra freezing equipment, what about the trucks from manufacture to the aircraft, the aircraft cargo, ground transporters, hospitals in major cities, etc, etc.
2020-11-12 19:32 | Report Abuse
Believe China Vaccine not working. See Brazil new cases have started to rise again 48,000 ++.
Believe also there was a fatal case in one of the volunteers.
2020-11-12 19:30 | Report Abuse
Believe China Vaccine not working. See Brazil new cases have started to rise again 48,000 ++.
Believe also there was a fatal case in one of the volunteers.
2020-11-12 19:30 | Report Abuse
Believe China Vaccine not working. See Brazil new cases have started to rise again 48,000 ++.
Believe also there was a fatal case in one of the volunteers.
2020-11-12 19:29 | Report Abuse
Believe China Vaccine not working. See Brazil new cases have started to rise again 48,000 ++.
Believe also there was a fatal case in one of the volunteers.
2020-11-12 19:22 | Report Abuse
To all AT shareholders, Pearl Glove is an industrial glove maker. Only RM 22 M deal. Small and insignificant. AT has already began building their medical glove manufacturing plant. 80% completed. Production to begin in December. They already have their order books for their production. Private placement investors have already committed funds to expand this manufacturing plant. TP 0.50 easy.
2020-11-11 14:14 | Report Abuse
Everyone should know this.
https://www.geo.tv/latest/317840-why-asian-countries-arent-betting-on-...
PFIZER VACCINE MAY NOT SUITABLE FOR ASIA COUNTRY.
Many Asian countries aren't betting on the experimental shot to solve their COVID-19 crisis any time soon given the tropical heat, and a dearth of ultra-cold freezers.
Health experts cautioned that the vaccine, should it be approved, was no silver bullet - not least because the genetic material it’s made from needs to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below.
Such requirements pose a particularly daunting challenge for countries in Asia, as well as in places like Africa and Latin America, where intense heat is often compounded by poor infrastructure that will make it difficult to keep the “cold chain” intact during deliveries to rural areas and islands.
That is a problem for everyone in the world, given the World Health Organization estimates about 70% of people must be inoculated to end the pandemic, and Asia alone is home to more than 4.6 billion - or three-fifths of the global population.
Some Asian countries are prioritising containing the novel coronavirus rather than looking to stockpile vaccines, while others are looking for alternatives to the messenger RNA technology used by Pfizer that requires such ultra-cold storage.
“On the cold chain requirement of -70 degrees, that is a hefty requirement. We do not have such facility,” Philippines’ Health Secretary Francisco Duque told Reuters.
“We will have to wait and see for now,” he added. “The technology Pfizer is using is new technology. We don’t have experience with that, so risks can be high.”
2020-11-11 13:51 | Report Abuse
Kwon Jun-wook, an official at South Korea’s Disease Control and Prevention Agency (KDCA), said it wanted to see how vaccination progressed in other countries first and would thoroughly review its supply chain.
The country had recently experienced the problems of cold storage when it had to discard about 5 million doses of flu vaccines because they were not stored at recommended temperatures.
2020-11-11 13:49 | Report Abuse
Everyone should know this.
https://www.geo.tv/latest/317840-why-asian-countries-arent-betting-on-pfizers-vaccine-to-solve-their-coronavirus-crisis
PFIZER VACCINE MAY NOT SUITABLE FOR ASIA COUNTRY.
Many Asian countries aren't betting on the experimental shot to solve their COVID-19 crisis any time soon given the tropical heat, and a dearth of ultra-cold freezers.
Health experts cautioned that the vaccine, should it be approved, was no silver bullet - not least because the genetic material it’s made from needs to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below.
Such requirements pose a particularly daunting challenge for countries in Asia, as well as in places like Africa and Latin America, where intense heat is often compounded by poor infrastructure that will make it difficult to keep the “cold chain” intact during deliveries to rural areas and islands.
That is a problem for everyone in the world, given the World Health Organization estimates about 70% of people must be inoculated to end the pandemic, and Asia alone is home to more than 4.6 billion - or three-fifths of the global population.
Some Asian countries are prioritising containing the novel coronavirus rather than looking to stockpile vaccines, while others are looking for alternatives to the messenger RNA technology used by Pfizer that requires such ultra-cold storage.
“On the cold chain requirement of -70 degrees, that is a hefty requirement. We do not have such facility,” Philippines’ Health Secretary Francisco Duque told Reuters.
“We will have to wait and see for now,” he added. “The technology Pfizer is using is new technology. We don’t have experience with that, so risks can be high.”
2020-11-11 13:48 | Report Abuse
Kwon Jun-wook, an official at South Korea’s Disease Control and Prevention Agency (KDCA), said it wanted to see how vaccination progressed in other countries first and would thoroughly review its supply chain.
The country had recently experienced the problems of cold storage when it had to discard about 5 million doses of flu vaccines because they were not stored at recommended temperatures.
2020-11-11 13:47 | Report Abuse
Kwon Jun-wook, an official at South Korea’s Disease Control and Prevention Agency (KDCA), said it wanted to see how vaccination progressed in other countries first and would thoroughly review its supply chain.
The country had recently experienced the problems of cold storage when it had to discard about 5 million doses of flu vaccines because they were not stored at recommended temperatures.
2020-11-11 13:47 | Report Abuse
Kwon Jun-wook, an official at South Korea’s Disease Control and Prevention Agency (KDCA), said it wanted to see how vaccination progressed in other countries first and would thoroughly review its supply chain.
The country had recently experienced the problems of cold storage when it had to discard about 5 million doses of flu vaccines because they were not stored at recommended temperatures.
2020-11-11 13:42 | Report Abuse
Everyone should know this.
https://www.geo.tv/latest/317840-why-asian-countries-arent-betting-on-pfizers-vaccine-to-solve-their-coronavirus-crisis
PFIZER VACCINE MAY NOT SUITABLE FOR ASIA COUNTRY.
Many Asian countries aren't betting on the experimental shot to solve their COVID-19 crisis any time soon given the tropical heat, and a dearth of ultra-cold freezers.
Health experts cautioned that the vaccine, should it be approved, was no silver bullet - not least because the genetic material it’s made from needs to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below.
Such requirements pose a particularly daunting challenge for countries in Asia, as well as in places like Africa and Latin America, where intense heat is often compounded by poor infrastructure that will make it difficult to keep the “cold chain” intact during deliveries to rural areas and islands.
That is a problem for everyone in the world, given the World Health Organization estimates about 70% of people must be inoculated to end the pandemic, and Asia alone is home to more than 4.6 billion - or three-fifths of the global population.
Some Asian countries are prioritising containing the novel coronavirus rather than looking to stockpile vaccines, while others are looking for alternatives to the messenger RNA technology used by Pfizer that requires such ultra-cold storage.
“On the cold chain requirement of -70 degrees, that is a hefty requirement. We do not have such facility,” Philippines’ Health Secretary Francisco Duque told Reuters.
“We will have to wait and see for now,” he added. “The technology Pfizer is using is new technology. We don’t have experience with that, so risks can be high.”
2020-11-11 13:42 | Report Abuse
Everyone should know this.
https://www.geo.tv/latest/317840-why-asian-countries-arent-betting-on-pfizers-vaccine-to-solve-their-coronavirus-crisis
PFIZER VACCINE MAY NOT SUITABLE FOR ASIA COUNTRY.
Many Asian countries aren't betting on the experimental shot to solve their COVID-19 crisis any time soon given the tropical heat, and a dearth of ultra-cold freezers.
Health experts cautioned that the vaccine, should it be approved, was no silver bullet - not least because the genetic material it’s made from needs to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below.
Such requirements pose a particularly daunting challenge for countries in Asia, as well as in places like Africa and Latin America, where intense heat is often compounded by poor infrastructure that will make it difficult to keep the “cold chain” intact during deliveries to rural areas and islands.
That is a problem for everyone in the world, given the World Health Organization estimates about 70% of people must be inoculated to end the pandemic, and Asia alone is home to more than 4.6 billion - or three-fifths of the global population.
Some Asian countries are prioritising containing the novel coronavirus rather than looking to stockpile vaccines, while others are looking for alternatives to the messenger RNA technology used by Pfizer that requires such ultra-cold storage.
“On the cold chain requirement of -70 degrees, that is a hefty requirement. We do not have such facility,” Philippines’ Health Secretary Francisco Duque told Reuters.
“We will have to wait and see for now,” he added. “The technology Pfizer is using is new technology. We don’t have experience with that, so risks can be high.”
2020-11-11 13:09 | Report Abuse
Reusable glove will not protect the patient. Ridiculous to even suggest.
2020-11-10 13:04 | Report Abuse
Pfizer Vaccine needs to be stored at minus 70 Deg C or 80 Deg C. That’s a tremendous logistical issue not only in the U.S. but outside the Western world,” said Dr Gregory Poland, a virologist and vaccine researcher with the Mayo Clinic.
2020-11-10 13:04 | Report Abuse
Pfizer Vaccine needs to be stored at minus 70 Deg C or 80 Deg C. That’s a tremendous logistical issue not only in the U.S. but outside the Western world,” said Dr Gregory Poland, a virologist and vaccine researcher with the Mayo Clinic.
2020-11-10 13:04 | Report Abuse
Pfizer Vaccine needs to be stored at minus 70 Deg C or 80 Deg C. That’s a tremendous logistical issue not only in the U.S. but outside the Western world,” said Dr Gregory Poland, a virologist and vaccine researcher with the Mayo Clinic.
2020-11-10 13:03 | Report Abuse
Pfizer Vaccine needs to be stored at minus 70 Deg C or 80 Deg C. That’s a tremendous logistical issue not only in the U.S. but outside the Western world,” said Dr Gregory Poland, a virologist and vaccine researcher with the Mayo Clinic.
2020-11-10 12:51 | Report Abuse
When vaccine is approved and ready for the masses, there will be a renewed surge in the demand for medical disposable golves. See all the links posted below. Just see the pictures where even to handle the vaccines gloves are used. And its 2 x doses over an interval per person. The world population is about 8 billion. So just imagine the demand. Currently itself supply unable to meet demand with the cases over 51 million. What more for 8 billion X 2 doses.
Picture paints a thousand words. Please see all 5 X links below
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.theedgemarkets.com/article/china-starts-testing-covid19-nasal-spray-vaccine&ved=2ahUKEwios7eA2OLrAhXTzTgGHcFNC_cQ0PADegQICRAJ&usg=AOvVaw1eGjgmw3mY1MKpOjOPJvQc
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.malaysiakini.com/news/542166&ved=2ahUKEwios7eA2OLrAhXTzTgGHcFNC_cQ0PADegQICRAX&usg=AOvVaw2GihnZPx6Wgz51YLYm47rU
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.thesundaily.my/local/advance-preparation-crucial-in-managing-covid-19-vaccine-ME3969871&ved=2ahUKEwios7eA2OLrAhXTzTgGHcFNC_cQ0PADegQICRAe&usg=AOvVaw0eYkoqCest4KK-Oigcp4jf
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.thestar.com.my/news/world/2020/09/10/who-says-700-million-raised-so-far-for-covid-19-vaccines-initiative-for-poor&ved=2ahUKEwios7eA2OLrAhXTzTgGHcFNC_cQ0PADegQICRAs&usg=AOvVaw1h76-e33Ow94mLqCrLnnj-
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.thestar.com.my/opinion/columnists/science-she-wrote/2020/09/11/the-covid-19-chronicles-goldilocks-and-the-37-vaccines&ved=2ahUKEwios7eA2OLrAhXTzTgGHcFNC_cQ0PADegQICRBI&usg=AOvVaw3qGDY0pCNlppIqcuVBKd3R
2020-11-10 12:51 | Report Abuse
When vaccine is approved and ready for the masses, there will be a renewed surge in the demand for medical disposable golves. See all the links posted below. Just see the pictures where even to handle the vaccines gloves are used. And its 2 x doses over an interval per person. The world population is about 8 billion. So just imagine the demand. Currently itself supply unable to meet demand with the cases over 51 million. What more for 8 billion X 2 doses.
Picture paints a thousand words. Please see all 5 X links below
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.theedgemarkets.com/article/china-starts-testing-covid19-nasal-spray-vaccine&ved=2ahUKEwios7eA2OLrAhXTzTgGHcFNC_cQ0PADegQICRAJ&usg=AOvVaw1eGjgmw3mY1MKpOjOPJvQc
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.malaysiakini.com/news/542166&ved=2ahUKEwios7eA2OLrAhXTzTgGHcFNC_cQ0PADegQICRAX&usg=AOvVaw2GihnZPx6Wgz51YLYm47rU
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.thesundaily.my/local/advance-preparation-crucial-in-managing-covid-19-vaccine-ME3969871&ved=2ahUKEwios7eA2OLrAhXTzTgGHcFNC_cQ0PADegQICRAe&usg=AOvVaw0eYkoqCest4KK-Oigcp4jf
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.thestar.com.my/news/world/2020/09/10/who-says-700-million-raised-so-far-for-covid-19-vaccines-initiative-for-poor&ved=2ahUKEwios7eA2OLrAhXTzTgGHcFNC_cQ0PADegQICRAs&usg=AOvVaw1h76-e33Ow94mLqCrLnnj-
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.thestar.com.my/opinion/columnists/science-she-wrote/2020/09/11/the-covid-19-chronicles-goldilocks-and-the-37-vaccines&ved=2ahUKEwios7eA2OLrAhXTzTgGHcFNC_cQ0PADegQICRBI&usg=AOvVaw3qGDY0pCNlppIqcuVBKd3R
2020-11-03 11:10 | Report Abuse
Clear manipulation. Don't fall in the trap. Just hold. Don't sell.
2020-11-02 23:46 | Report Abuse
All were sold at Direct Business Transaction.
Direct Business Transaction
Direct Business Transaction (DBT) encompasses any trades transacted outside Bursa Malaysia’s Automated Trading System(ATS) but reported in ATS.
Such transactions include:
1) Crossing Trade = Transaction between two Participating Organizations.
It is a Direct Business transaction in securities between two clients of different Participating Organizations.
2) Married Trade = Transaction between two clients within a
Participating Organization.
All these has got to do with their expansion.
2020-11-02 23:12 | Report Abuse
Ok. Lets go with windfall tax. Sell, Sell, Sell. Share price drop below RM 7, I will surely buy and collect.
3 research house have already announced their TP - ranginging from RM 12 - RM 16.
2020-11-02 23:09 | Report Abuse
So what is there is windfall tax. For 1B PBT, a small fraction would not make a difference. In return the Govt will reward with incentives. Win win.
IBs are just trying to spook the market so that they can by cheap shares.
2020-11-02 15:09 | Report Abuse
All being manipulated. with the current local and US politics, very easy to spook the market. When price drops, they buy and make easy gains. All those who sold have fallen into their trap. This happened last week and now. Will continue to happen so long as there are retailers / uncles / aunties who are easily duped. If you guys do not sell, they will not be able to manipulate the share price. When will you all learn?
2020-11-01 23:10 | Report Abuse
EPF has increased their shareholding in TG. Any windfall tax will only hurt EPF which is the Govt Fund. So its obvious there is no windfall tax. Also TG boss already announced that any windfall tax would only push glove manufacturers to expand overseas and not Malaysia. Discussed already in previous parliament sitting. No windfall tax.
2020-10-31 16:46 | Report Abuse
Employees Provident Fund (EPF) has bought an additional 51.35 million shares, raising its stake in Top Glove to 5.67% as at Oct 27, compared with 5.05% as at Sept 21.
2020-10-31 16:43 | Report Abuse
While Top Glove’s director was selling shares, the Employees Provident Fund (EPF) was doing the opposite. The provident fund has bought an additional 51.35 million shares, raising its stake in Top Glove to 5.67% as at Oct 27, compared with 5.05% as at Sept 21.
2020-10-31 13:41 | Report Abuse
3rd Quarter - 30-Sep-2020 Revenue - 1.35B PBT - 1.049B PAT - 812.5M
Almost 100% increase from 2nd Quarter this year. 4th Quarter projected at another 150 - 200% increase.
many countries are stocking up gloves like gold reserves.
2020-10-31 13:28 | Report Abuse
28/10/2020 TP 13.83 +3.92 (39.56%) BUY MIDF
28/10/2020 TP 12.00 +2.09 (21.09%) BUY KENANGA
28/10/2020 TP 16.40 +6.49 (65.49%) BUY AffinHwang
See above under Research, Price Target
2020-10-26 15:14 | Report Abuse
No windfall tax. Gov already discussed this. Instead they are providing incentives to support. That is why many companies are trying to jump in the band wagon. So best to stop this rumours.
2020-10-22 12:46 | Report Abuse
Counter is being manipulated to cause panic so that you would sell and others will pick up. They are pressing it down because very soon its going to shoot past RM 13.50. They want to make huge profits from your low selling. So dont sell now. Hold and collect more. This is what I have been observing these past few months.
2020-10-22 12:42 | Report Abuse
Already confirmed NO windfall tax. Instead Govt providing further support. All positive.
2020-10-21 23:52 | Report Abuse
Disagree with MoneyMakers. Glove counters are here to stay. Even with vaccine, gloves are used. Viruses mutate, like the flu virus which continues to be around for decades.
2020-09-28 13:25 | Report Abuse
He is a former MD. Already history. No impact on Supermax. Don't be fooled. Share price will go up due fundamentals are very strong.
2020-09-22 21:30 | Report Abuse
Just hold and the share price will continue to go up. Believe in fundamentals. Also gloves are truly Malaysia. From raw material to finished product. So support products that are truly Malaysia.
2020-09-22 21:29 | Report Abuse
Just hold and the share price will continue to go up. Believe in fundamentals. Also gloves are truly Malaysia. From raw material to finished product. So support products that are truly Malaysia.
2020-09-22 21:28 | Report Abuse
Just hold and the share price will continue to go up. Believe in fundamentals. Also gloves are truly Malaysia. From raw material to finished product. So support products that are truly Malaysia.
2020-09-21 21:20 | Report Abuse
Experts have been particularly concerned about AstraZeneca’s vaccine trials, which began in April in Britain, because of the company’s refusal to provide details about serious neurological illnesses in two participants, both women, who received its experimental vaccine in Britain. Those cases spurred the company to halt its trials twice, the second time earlier this month. The studies have resumed in Britain, Brazil, India and South Africa, but are still on pause in the U.S. About 18,000 people worldwide have received AstraZeneca’s vaccine so far.
Stock: [CAREPLS]: CAREPLUS GROUP BERHAD
2020-11-13 11:35 | Report Abuse
DJ -400, S&P -90